Restenosis after directional coronary atherectomy and balloon angioplasty: Comparative analysis based on matched lesions

This publication has 30 references indexed in Scilit:

• Restenosis after coronary angioplasty: a proposal of new comparative approaches based on quantitative angiography
  Heart, 1992
• Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
  Circulation, 1992
• Novel approach to the analysis of restenosis after the use of three new coronary devices
  Journal of the American College of Cardiology, 1992
• Lumen narrowing after percutaneous transluminal coronary balloon angioplasty follows a near gaussian distribution: A quantitative angiographic study in 1,445 successfully dilated lesions
  Journal of the American College of Cardiology, 1992
• Postangioplasty restenosis rate between segments of the major coronary arteries
  The American Journal of Cardiology, 1992
• Relative risk analysis of angiographic predictors of restenosis within the coronary Wallstent.
  Circulation, 1991
• Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study (CARPORT).
  Circulation, 1991
• Quantitative angiography after directional coronary atherectomy.
  Heart, 1991
• Delayed rupture of right coronary artery after directional atherectomy for bail-out
  American Heart Journal, 1991
• Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months.
  Circulation, 1988